Clinical Trial Update: A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients. [Phase 1]

View source ↗

Summary

Phase 1 trial update for iN1011-N17 assessing safety, tolerability, and PK/PD in healthy volunteers and postherpetic neuralgia patients; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Osteoarthritis
• Pain
• Postherpetic Neuralgia

Drugs mentioned

• iN1011-N17

Snippet

Sponsor: iN Therapeutics Co., Ltd. | Conditions: Post Herpetic Neuralgia, Pain | Phase 1 | Status: RECRUITING